johnson & johnson - search results

If you're not happy with the results, please do another search

Integra LifeSciences to acquire Codman Neurosurgery business from Johnson & Johnson

Integra LifeSciences Holdings Corporation has made a binding offer to acquire the Johnson & Johnson Codman Neurosurgery business for a price of US$1.045 billion in...

Clarimedix secures investment for proof-of-concept study in cerebral vasospasm

Clarimedix announced that Johnson & Johnson Corporate Office of Science and Technology (COSAT) has secured an investment for a human proof-of-concept study to determine the viability of a powerful nitric oxide donor alternative for the treatment of cerebral vasospasm, Raynaud's phenomenon, and Alzheimer's disease.
cerenovus stroke care

Cerenovus to unveil new data and showcase stroke care innovations at SNIS annual meeting

Cerenovus, a neurovascular firm that forms part of The Johnson & Johnson Medical Devices Companies, will showcase its latest innovations in stroke care at...

Cerenovus unveils new clot extractor device in European launch

  Cerenovus, part of Johnson & Johnson Medical Devices Companies, has today announced the European launch of Cerenovus Nimbus, a device designed to remove tough clots for successful revascularisation in patients...

Cerenovus launches new suite of technologies to advance stroke treatment

Cerenovus recently announced that it has launched Stroke Solutions, which includes a suite of three devices designed to aid physicians in clot removal procedures....

Type of stent denotes degree of complete occlusion following stent-assisted coiling of cerebral aneurysms

A study comparing three different stents used during stent-assisted coiling of cerebral aneurysms revealed that the type of stent used affects a patient’s immediate...

Cerenovus launches largest global registry to study stroke-inducing blood clots removed by thrombectomy

Johnson & Johnson has announced that its Cerenovus business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyse stroke-inducing...

First intracranial aneurysm patients treated with BRAVO Flow Diverter

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced that the first patients have been treated with the BRAVO Flow Diverter,...

BRAVO flow diverter receives European regulatory approval

CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, has announced it has received European CE mark approval for its BRAVO flow diverter....

Christopher M Smith joins Neuromod Board as strategic advisor

Neuromod Devices Limited (“Neuromod”), an Irish medical technology company specialising in non-invasive neuromodulation technologies, has announced that Christopher M Smith became Strategic Advisor to...

Cerenovus launches next generation embolic coil for treatment of cerebral aneurysms and stroke

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced the launch of the Galaxy G3 mini coil, its smallest and softest...

Cerenovus launches in Europe

Johnson & Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the European Society of Minimally Invasive Neurological Therapy (ESMINT) 9th Annual...

Cerenovus introduced at SNIS

Johnson & Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the Society of NeuroInterventional Surgery 14th Annual Meeting (SNIS; 24–28 July,...

Codman Neuro acquires Neuravi

Codman Neuro has announced the acquisition of Neuravi. This acquisition comes after the company’s recent acquisition of Pulsar Vascular, expanding its products for stroke...

Codman Neuro announces acquisition of Pulsar Vascular Inc

Codman Neuro has announced the acquisition of Pulsar Vascular Inc, a privately-held company with breakthrough platform technology for the neurovascular treatment of complex aneurysms. DePuy...

Codman Neuro agrees US distribution of InNeuroCo intermediate catheters

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has entered into an agreement with InNeuroCo for exclusive US and European distribution...

Codman Certas Plus programmable valve offers new versatility in treating hydrocephalus

Codman Neuro has developed a new MRI-resistant programmable valve with eight different pressure settings, including a ‘virtual off’ setting, for the treatment of hydrocephalus. The...

Neuravi appoints Robert Stern to board of directors

Neuravi has announced that Robert A Stern has joined the company’s board of directors. Stern has more than 25 years of experience as a senior executive...

Codman Neuro launches family of coils for treatment of brain aneurysms

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has introduced a new platform of embolic coils for the treatment of brain...

Comprehensive stroke centres may improve bleeding stroke survival

People with haemorrhagic strokes are more likely to survive if they are treated at a comprehensive stroke centre, according to research published in the Journal of the American Heart Association.

First biosynthesised cellulose-based dural replacement for neurosurgery launched

DePuy Synthes CMF has announced the launch of Synthecel Dura Repair, the first commercially available biosynthesised dural replacement derived from cellulose for use in neurosurgery.

Codman Neuro launches Enterprise 2 in Europe

The Enterprise 2 system is the latest generation of the company's self-expanding stent and delivery system used to treat wide-necked intracranial aneurysms and to help maintain the position of endovascular coils.

Is it dementia, or just normal aging? New tool may help triage

Researchers at Mayo Clinic developed a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking problems that can lead to dementia.

Codman Neuro gains exclusive rights to market and promote PulseRider in Europe, the Middle...

PulseRider is a minimally invasive device intended for use with embolic coils in the treatment of unruptured wide-neck intracranial aneurysms originating on or near a bifurcation.

Revive SE thrombectomy device approved in China, South Korea and Taiwan

The Revive SE Device from Codman Neuro is designed to ease navigation through small and tortuous blood vessels and arteries in the cerebral vasculature. The new device enables rapid restoration of blood flow to the brain during an acute ischaemic stroke.

Myelin Repair Foundation and NIH enter into agreement to repurpose MRF-008 for multiple sclerosis

The Myelin Repair Foundation has announced that it has entered a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) to assess MRF-008, as a potential therapeutic for multiple sclerosis. The NIH are expect to instigate a clinical trial to assess this.

Zynex to acquire NeuroDyne Medical assets

NeuroDyne Medical produces devices for evaluation and treatment of neurological and neuromuscular disorders.

Codman Neurovascular launches Orbit Galaxy detachable coil system

Orbit Galaxy features the first complete family of complex, random loop coils for the endovascular treatment of cerebral aneurysms, in the market.
else charlotte sandset

Else Charlotte Sandset

william mack

William Mack

mitchell elkind

Mitchell Elkind